The Jordanian Pharmaceutical Manufacturing Co. PLC Stock Forecast for 2022 - 2025 - 2030

Updated on 09/27/2022

Stock Rating
0
Price Target
0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
0
Upside
0.00%
Analysts
0
Price Target
0.00
-

The Jordanian Pharmaceutical Manufacturing Co. PLC Fair Value Forecast for 2022 - 2025 - 2030

In the last three years, The Jordanian Pharmaceutical Manufacturing Co. PLC's Price has grown by 100.00%, rising from 0.00 to 0.00. For the next year, analysts predict that Fair Value will reach 0.00 – an increase of 100.00%. Over the next nine years, experts believe that The Jordanian Pharmaceutical Manufacturing Co. PLC's Fair Value will grow at a rate of 100.00%.

2022 Fair Value Forecast
0.00
2023 Fair Value Forecast
0.00
2024 Fair Value Forecast
0.00
2025 Fair Value Forecast
0.00
2026 Fair Value Forecast
0.00
2027 Fair Value Forecast
0.00
2028 Fair Value Forecast
0.00
2029 Fair Value Forecast
0.00
2030 Fair Value Forecast
0.00

The Jordanian Pharmaceutical Manufacturing Co. PLC Revenue Forecast for 2022 - 2025 - 2030

In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC's Revenue has decreased from 22.21M to 9.98M – a 55.07% drop. For the next year, analysts predict that Revenue will reach 22.21M – an increase of 122.55%. Over the next eleven years, experts believe that The Jordanian Pharmaceutical Manufacturing Co. PLC's Revenue will grow at a rate of 5223.89%.

2020 Rev Forecast
0.02B
2021 Rev Forecast
0.04B
2022 Rev Forecast
0.07B
2023 Rev Forecast
0.10B
2024 Rev Forecast
0.14B
2025 Rev Forecast
0.19B
2026 Rev Forecast
0.24B
2027 Rev Forecast
0.30B
2028 Rev Forecast
0.37B
2029 Rev Forecast
0.45B
2030 Rev Forecast
0.53B

The Jordanian Pharmaceutical Manufacturing Co. PLC Dividend per Share Forecast for 2022 - 2025 - 2030

The Jordanian Pharmaceutical Manufacturing Co. PLC Free Cash Flow Forecast for 2022 - 2025 - 2030

The Jordanian Pharmaceutical Manufacturing Co. PLC's Free Cash Flow has decreased by 15.97% In the last year, from -2.38M to -2.00M. In the next year, analysts believe that Free Cash Flow will reach -2.38M – an increase of 19.00%. For the next eleven years, the forecast is forFree Cash Flow to grow by 14.20%.

2020 FCF Forecast
-2380000.00
2021 FCF Forecast
-2277342.67
2022 FCF Forecast
-2334579.88
2023 FCF Forecast
-2226333.19
2024 FCF Forecast
-2277687.28
2025 FCF Forecast
-2278902.04
2026 FCF Forecast
-2298348.67
2027 FCF Forecast
-2274216.01
2028 FCF Forecast
-2275428.93
2029 FCF Forecast
-2276642.49
2030 FCF Forecast
-2283927.75

The Jordanian Pharmaceutical Manufacturing Co. PLC Net Income Forecast for 2022 - 2025 - 2030

In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC's Net Income has seen an increase, rising from -4.10M to -5.86M. This represents a growth of 42.93%. For the following year, the 0 analysts predict that The Jordanian Pharmaceutical Manufacturing Co. PLC's Net Income will drop by 30.03%, reaching -4.10M. In 2030, the professionals' prediction is that JPHM's Net Income will decrease by 16.25%, reaching -4.91M.

2020 NI Forecast
-4100242.00
2021 NI Forecast
-4863023.69
2022 NI Forecast
-4817635.47
2023 NI Forecast
-5270011.44
2024 NI Forecast
-4860180.21
2025 NI Forecast
-4872978.69
2026 NI Forecast
-4866318.95
2027 NI Forecast
-5001115.99
2028 NI Forecast
-4954105.49
2029 NI Forecast
-4927518.46
2030 NI Forecast
-4907644.14

The Jordanian Pharmaceutical Manufacturing Co. PLC EBITDA Forecast for 2022 - 2025 - 2030

In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC's EBITDA has decreased from 1.37M to -5.87M – a 528.47% drop! In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach -13.11M – an increase of 123.34%. Over the next eleven years, experts anticipate that EBITDA growth for The Jordanian Pharmaceutical Manufacturing Co. PLC will be 135.99%.

2020 EBITDA Forecast
-13110058.00
2021 EBITDA Forecast
-13672916.49
2022 EBITDA Forecast
-16589349.58
2023 EBITDA Forecast
-12335287.37
2024 EBITDA Forecast
-12861181.79
2025 EBITDA Forecast
-13410782.95
2026 EBITDA Forecast
-14586461.59
2027 EBITDA Forecast
-13796361.59
2028 EBITDA Forecast
-13500659.57
2029 EBITDA Forecast
-13494359.27
2030 EBITDA Forecast
-13852859.41

The Jordanian Pharmaceutical Manufacturing Co. PLC EBIT Forecast for 2022 - 2025 - 2030

In the last year, The Jordanian Pharmaceutical Manufacturing Co. PLC has seen a decline in its EBIT, from 780.00k to -6.29M – a 906.41% decrease. In the next year, analysts predict that EBIT will reach -13.36M – an increase of 112.40%. For the next eleven years, the forecast is for EBIT to grow by 119.42%.

2020 EBIT Forecast
-13359960.00
2021 EBIT Forecast
-13652097.79
2022 EBIT Forecast
-16261468.75
2023 EBIT Forecast
-12406958.61
2024 EBIT Forecast
-12939630.70
2025 EBIT Forecast
-13409770.61
2026 EBIT Forecast
-14457520.69
2027 EBIT Forecast
-13740427.66
2028 EBIT Forecast
-13486687.77
2029 EBIT Forecast
-13479944.42
2030 EBIT Forecast
-13801216.43

The Jordanian Pharmaceutical Manufacturing Co. PLC EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS has grown by 525.00%, rising from -0.04 to -0.25. For the next year, analysts predict that EPS will reach -0.55 – an increase of 119.00%. Over the next nine years, experts believe that The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS will grow at a rate of 210.37%.

2022 EPS Forecast
-0.55
2023 EPS Forecast
-1.25
2024 EPS Forecast
-0.44
2025 EPS Forecast
-0.55
2026 EPS Forecast
-0.75
2027 EPS Forecast
-1.09
2028 EPS Forecast
-0.81
2029 EPS Forecast
-0.75
2030 EPS Forecast
-0.78